Excessive pricing cases in the pharmaceutical industry: Economic considerations and practical pitfalls

Excessive pricing cases in the pharmaceutical industry: Economic considerations and practical pitfalls

Raphaël De Coninck, Elina Koustoumpardi
Antitrust & Competition | European competition

This article highlights the main conceptual difficulties with excessive pricing cases, and argues that such cases should be limited to truly exceptional circumstances. The authors discuss the numerous practical difficulties in determining whether a price can be considered as excessive, and the main pitfalls to avoid. To read the article, click the link below.

Download PDF